Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Immunological Medicines for Poultry

Immunological veterinary medicinal products, including vaccines, are authorised for poultry.

Search results 126 to 136 from a total of 136

Name De­scrip­tion Mar­ket­ing Au­tho­ri­sa­tion Hold­er Li­cense Num­ber Li­cense Date An­i­mal Further Information

Dindoral SPF

Infektiöse Hämorrhagische Enteritis

Boehringer Ingelheim Vetmedica GmbH

5a/95 22.07.1996 Pute

Terivac

Infektiöse Rhinotracheitis

Boehringer Ingelheim Vetmedica GmbH

106a/90 18.11.1998 Pute

Trituren

Newcastle Disease,
Paramyxovirose der Pute,
Infektiöse Rhinotracheitis

Boehringer Ingelheim Vetmedica GmbH

38a/92 27.12.1994 Pute

Poulvac TRT

Infektiöse Rhinotracheitis

Zoetis Deutschland GmbH

PEI.V.01721.01.1 05.12.2000 Pute

Chevivac-P12

Paramyxovirose der Taube

chevita Tierarzneimittel GmbH

235a/97 19.06.1998 Taube

Pharmavac PHA

Paramyxovirose der Taube, Infektion mit Tauben-Herpesvirus, Infektion mit Aviärem Adenovirus

Pharmagal Bio, spol.s.r.o., Slowakei

PEI.V.11963.01.1 15.10.2018 Taube

Chevivac PMV

Paramyxovirose der Taube

chevita Tierarzneimittel GmbH

PEI.V.11653.01.1 04.10.2012 Taube

Chevivac-S

Salmonellen-Infektion

chevita Tierarzneimittel GmbH

PEI.V.00272.01.1 18.05.1998 Taube

Nobilis Paramyxo P201

Paramyxovirose der Taube

Intervet Deutschland GmbH

243a/97 28.03.2000 Taube

Chevipok

Taubenpocken

chevita Tierarzneimittel GmbH

PEI.V.11530.01.1 24.06.2011 Taube

RP Vacc

Paramyxovirose der Taube, Rotavirus-Infektion der Taube

Pharmagal Bio, spol.s.r.o., Slowakei

PEI.V.12101.01.1 06.12.2021 Taube

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 530 in BAnz AT 16.06.2025 B4.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 17.06.2025